VAD I protocol

Known as: DM/DOX/VCR, Dexamethasone/Doxorubicin/Vincristine, VAD 
 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsDexamethasonecisplatin/cyclophosphamide/etoposide protocol
DoxorubicinDoxorubicin HydrochlorideVincristine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Subjective comparison and evaluation of speech enhancement algorithms
Making meaningful comparisons between the performance of the various speech enhancement algorithms proposed over the years, has… (More)
  • table 2
  • figure 1
  • table 3
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma
While initial therapies have become highly effective with introduction of lenalidomide and bortezomib and patients may opt for… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain.
RIP3 (Receptor Interacting Protein 3), a member of the Ser/Thr kinase family, is able to induce apoptosis and activate NF-kappaB… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study.
BACKGROUND Current ventricular assist devices (VADs) in the United States are designed primarily for adult use. Data on VADs as a… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
The aim of the present study was to compare thalidomide-dexamethasone (Thal-Dex) and vincristine-doxorubicin-dexamethasone (VAD… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death.
Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of many diseases and in cancer therapy. Although the… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells.
The effect of fucoxanthin, from the edible seaweed Undaria pinnatifida on viability of colon cancer cells and induction of… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?
Cerebrospinal fluid (CSF) biochemical markers for Alzheimer disease (AD) would be of great value to improve the clinical… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Modulation of multidrug-resistant multiple myeloma by cyclosporin
Resistance to chemotherapy in refractory multiple myeloma is frequently associated with expression of multidrug resistance (MDR… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
VAD-based regimens as primary treatment for multiple myeloma.
An alternating VCAD-VAD regimen, combining vincristine-doxorubicin by continuous infusion with cyclophosphamide and pulse… (More)
Is this relevant?